InsidersTradesSigma
沃森生物 Stock: price and directors' dealings · China · SSE / SZSE (CSRC)
Track the 沃森生物 stock price and the full management transaction log of the company, a listed equity based in China. Shares trade on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 沃森生物 has recorded 13 public disclosures. Market capitalisation: €17.4bn. The latest transaction was filed on 27 February 2023 (Purchase). Among the most active insiders: 广州盈沃企业管理合伙企业(有限合伙). Every trade is free.
13
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
11 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 15,319 of 25,791 companies
46.3
score / 100
Value28
Quality65
FCF yld-0.1%
Earn yld0.9%
EV/EBITDA36.7x
ROE2.7%
Gross mgn75%
Net mgn7.4%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 27 February 2023
Declarations13 total
667,600 sharesA股XSHESZSE:173000006349769820
Ideal exit: 24 Nov 2023 (T+270)
1,968,200 sharesA股XSHESZSE:173000006286409570
Ideal exit: 14 Nov 2023 (T+270)
77,600 sharesA股XSHESZSE:173000006177297860
53,500 sharesA股XSHESZSE:173000006166610560
13 of 13 declarations